Published in Diabetes on April 01, 2000
Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest (2000) 2.80
Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes (2010) 2.10
Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag (2007) 1.88
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81
Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther (2010) 1.46
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol (2008) 1.44
Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest (2001) 1.41
Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) (2010) 1.13
Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes. Diabetes Metab Syndr Obes (2011) 1.05
PAI-1 and diabetes: a journey from the bench to the bedside. Diabetes Care (2012) 0.99
Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease. Curr Drug Targets (2011) 0.93
Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes. Atherosclerosis (2007) 0.88
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. Int J Med Sci (2016) 0.88
Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population. Exp Diabetes Res (2012) 0.78
Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review. Clin Kidney J (2016) 0.75
PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin-sensitizing drugs. Am J Reprod Immunol (2017) 0.75
[Revascularization of coronary artery disease in diabetes mellitus]. Wien Med Wochenschr (2010) 0.75
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol (2000) 4.25
Estimation of infarct size in man and its relation to prognosis. Circulation (1972) 4.19
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest (1981) 3.34
Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes (1996) 3.21
Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest (1971) 3.11
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest (1980) 3.10
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest (1987) 2.81
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest (2000) 2.67
Rubredoxin: a new electron transfer protein from Clostridium pasteurianum. Proc Natl Acad Sci U S A (1965) 2.55
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem (1987) 2.48
The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes (1985) 2.46
Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest (1980) 2.41
LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes (1981) 2.40
Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol (1992) 2.39
Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest (1973) 2.28
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol (1972) 2.19
The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes (1976) 2.15
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation (1972) 2.10
Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res (1970) 2.02
Mechanisms of insulin resistance in aging. J Clin Invest (1983) 2.00
Protection of jeopardized ischemic myocardium by reduction of ventricular afterload. N Engl J Med (1974) 1.92
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care (1992) 1.92
In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest (1986) 1.87
Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest (1972) 1.86
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med (1982) 1.85
Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med (1974) 1.84
Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res (1984) 1.83
Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem (1994) 1.79
Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest (1972) 1.78
An improved basis for enzymatic estimation of infarct size. Circulation (1975) 1.77
Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest (1987) 1.76
The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1976) 1.75
Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci U S A (2009) 1.75
The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation (1979) 1.75
Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem (1996) 1.74
Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem (1996) 1.71
Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care (1983) 1.71
Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. Am Heart J (1988) 1.69
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest (1975) 1.69
Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res (1978) 1.67
Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. J Clin Invest (1976) 1.66
Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes. Bioinformatics (2004) 1.65
Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation (1976) 1.65
Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation. J Biol Chem (1995) 1.65
Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol (1990) 1.65
Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol (1977) 1.65
On-line assessment of ventricular function by automatic boundary detection and ultrasonic backscatter imaging. J Am Coll Cardiol (1992) 1.62
Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes (1996) 1.60
Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation (1972) 1.60
Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1975) 1.59
Characteristics of Clostridium pasteurianum ferredoxin in oxidation-reduction reactions. Biochemistry (1966) 1.58
Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res (1972) 1.58
G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol (1999) 1.58
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med (1984) 1.57
Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.55
Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes (1990) 1.54
Insulin binding to isolated human adipocytes. Diabetes (1974) 1.53
Effects of fasting on insulin binding, glucose transport, and glucose oxidation in isolated rat adipocytes: relationships between insulin receptors and insulin action. J Clin Invest (1976) 1.52
Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1985) 1.51
Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol (1974) 1.51
Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes. Biochem J (1978) 1.51
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes (1994) 1.50
Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation (1972) 1.50
Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology (1975) 1.50
Effects of streptozotocin-induced diabetes on insulin binding, glucose transport, and intracellular glucose metabolism in isolated rat adipocytes. Diabetes (1979) 1.50
Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis. Circulation (1995) 1.49
Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes (1977) 1.49
Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest (1988) 1.49
Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors. Circulation (1989) 1.48
Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation (1991) 1.47
Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes (1994) 1.46
Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Investig Med (1996) 1.45
Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J Clin Invest (1978) 1.45
Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling. J Biol Chem (1996) 1.45
Augmented myocardial perfusion reserve after coronary angioplasty quantified by positron emission tomography with H2(15)O. J Am Coll Cardiol (1990) 1.44
Population structure and history in East Asia. Proc Natl Acad Sci U S A (2000) 1.44
Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem (1994) 1.43
Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med (1981) 1.43
Potentiation of vasculopathy by insulin: implications from an NHLBI clinical alert. Circulation (1996) 1.42
Effects of lysosomotropic agents on insulin interactions with adipocytes. Evidence for a lysosomal pathway for insulin processing and degradation. J Biol Chem (1979) 1.42
Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction. J Clin Invest (1973) 1.42
Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes (1986) 1.41
Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem (1987) 1.41
Relation between infarct size and ventricular arrhythmia. Br Heart J (1975) 1.41
Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol (1975) 1.40
Evidence for recycling of insulin receptors in isolated rat adipocytes. J Biol Chem (1981) 1.38
Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions. Cathet Cardiovasc Diagn (1998) 1.38
Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol (1982) 1.38
Decreased insulin binding to lymphocytes from diabetic subjects. J Clin Invest (1974) 1.37
The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem (2000) 1.35
beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem (2001) 1.35
Relationship between in vivo insulin resistance and decreased insulin receptors in obese man. J Clin Endocrinol Metab (1979) 1.34
Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest (1978) 1.34
Ediortial: Isoenzymes of creatine phosphokinase and diagnosis of myocardial infarction. Ann Intern Med (1973) 1.33
Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc Natl Acad Sci U S A (1994) 1.33
Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J (1984) 1.33